- TRADE NAMES: Ambi (Johnson & Johnson); Lustra (Taro)
- INDICATIONS: Ultraviolet induced dyschromia and discoloration resulting from the use of oral contraceptives, pregnancy, hormone replacement therapy, or skin trauma
- CLASS: Depigmentation agent
- HALF-LIFE: N/A
- CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
None known
Please login to view the rest of this drug profile.
Page last updated 08/20/2025
